There is new hope for people with migraines. The debilitating headaches are on of the leading causes of disability in Canada. But Health Canada has approved two new treatments, the medications Qulipta, and Ubrelvy. Migraine expert Dr. Werner Becker joined ‘Global News at Noon Edmonton’ to share more about what this means for patients.
Global News at Noon Edmonton
New migraine medications a gamechanger for Canadians: migraine expert
More Videos
-
Mitigating fire risk in Edmonton
-
Edmonton special Olympic athlete chosen in local advertising campaign
-
Education minister highlights changes in new draft of social studies curriculum
-
Edmonton city council needs to have a ‘firmer backbone’ over budget: Tim Cartmell
-
Alberta Wildfire provides update on current status in the province
-
Edmonton police release footage of suspects in extortion of South Asian community
You are viewing an Accelerated Mobile Webpage.
View Original Article